Krensavage Asset Management, LLC Elanco Animal Health Inc Transaction History

Krensavage Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 18, 2020	SELL	$25.29 - $29.45 $22.6 Million - $26.3 Million	-892,620 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$25.62 - $34.96 $19,701 - $26,884	769 Added 0.09%	892,620 $23.7 Million
Q2 2019 Aug 14, 2019	SELL	$31.11 - $34.79 $384,239 - $429,691	-12,351 Reduced 1.37%	891,851 $30.1 Million
Q1 2019 May 15, 2019	BUY	$29.0 - $32.83 $20.4 Million - $23.1 Million	703,235 Added 349.93%	904,202 $29 Million
Q4 2018 Feb 15, 2019	SELL	$29.63 - $34.5 $11,703 - $13,627	-395 Reduced 0.2%	200,967 $6.34 Million
Q4 2018 Feb 14, 2019	BUY	$29.63 - $34.5 $40,356 - $46,989	1,362 Added 0.68%	201,362 $6.16 Million
Q3 2018 Nov 14, 2018	BUY	$34.1 - $36.19 $6.82 Million - $7.24 Million	200,000 New	200,000 $6.98 Million

447

478M

3.1M

1.26M

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.96B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Krensavage Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Krensavage Asset Management, LLC with notifications on news.